Safety and efficacy of topical steroid administration in patients undergoing mandibular horizontal impacted wisdom tooth extraction

aruse Tomofumi0 sites246 target enrollmentMarch 28, 2022

Overview

No summary available.

Registry

who.int

Start Date

March 28, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

aruse Tomofumi

•1\. patients who are planned to undergo mandibular horizontal impacted wisdom tooth extraction
•2\. Patients who can personally provide written consent at their own free will after being receiving a thorough explanation of the study and fully understanding their participation in the study.

•Any of the following patients will be excluded:
•1\. Patients with problem in judgement.
•2\. Patients receiving therapies with anti\-resorption drugs.
•3\. Patients with a history of radiation therapy to the jawbone.
•4\. Patients are immunocompromised with steroid or immunosuppressants.
•5\. Patients receiving therapies with antithrombotic therapy.
•6\. Patients for whom administration of Sol\-Corteph, Spongel, Amoxicillin, Loxoprofen Sodium Hydrate or Acetaminophen is contraindicated.
•7\. Patients receiving therapies with Desmopressin Acetate Hydrate
•8\. Patients who receive analgesics for pain at least once a week (e.g., cancer pain, non\-cancer pain). However, topical analgesics and anti\-inflammatory drugs (patches and applications) are allowed.
•9\. Women who are or may be pregnant or lactating women.